Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP673523.RANEb5FXMllv7A07391PJYQ7Sjmf8SDDhd-3B-GsWMJ6U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP673523.RANEb5FXMllv7A07391PJYQ7Sjmf8SDDhd-3B-GsWMJ6U130_assertion type Assertion NP673523.RANEb5FXMllv7A07391PJYQ7Sjmf8SDDhd-3B-GsWMJ6U130_head.
- NP673523.RANEb5FXMllv7A07391PJYQ7Sjmf8SDDhd-3B-GsWMJ6U130_assertion description "[Nonclassic adrenal hyperplasia should be excluded in all women presenting with hirsutism, with use of a basal follicular phase 17-hydroxyprogesterone level, regardless of the presence of polycystic ovaries or metabolic dysfunction; however, women with nonclassic adrenal hyperplasia have a higher prevalence of normal ovulation and lower likelihood of having an LH/FSH ratio >2 or polycystic ovaries.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP673523.RANEb5FXMllv7A07391PJYQ7Sjmf8SDDhd-3B-GsWMJ6U130_provenance.
- NP673523.RANEb5FXMllv7A07391PJYQ7Sjmf8SDDhd-3B-GsWMJ6U130_assertion evidence source_evidence_literature NP673523.RANEb5FXMllv7A07391PJYQ7Sjmf8SDDhd-3B-GsWMJ6U130_provenance.
- NP673523.RANEb5FXMllv7A07391PJYQ7Sjmf8SDDhd-3B-GsWMJ6U130_assertion SIO_000772 19726039 NP673523.RANEb5FXMllv7A07391PJYQ7Sjmf8SDDhd-3B-GsWMJ6U130_provenance.
- NP673523.RANEb5FXMllv7A07391PJYQ7Sjmf8SDDhd-3B-GsWMJ6U130_assertion wasDerivedFrom befree-20150227 NP673523.RANEb5FXMllv7A07391PJYQ7Sjmf8SDDhd-3B-GsWMJ6U130_provenance.
- NP673523.RANEb5FXMllv7A07391PJYQ7Sjmf8SDDhd-3B-GsWMJ6U130_assertion wasGeneratedBy ECO_0000203 NP673523.RANEb5FXMllv7A07391PJYQ7Sjmf8SDDhd-3B-GsWMJ6U130_provenance.